XBIO
Xenetic Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.67
+0.86%Margins
Gross margin
100.0%
EBITDA margin
-75.9%
EBIT margin
-81.0%
Net margin
-75.9%
FCF margin
-70.9%
-40.8%
Return on equity
-35.5%
Return on assets
-43.5%
Return on invested capital
0.44x
Asset turnover
-$2.3M
Cash from operations
$2.76
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026